The efficacy and safety of rituximab in adult patients with steroid-dependent or frequent relapsing nephrotic syndrome: A retrospective study
Authors:
- 10 May 2025
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 158, 114795
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82090021, 82070732, 82325009)
- Chinese Academy of Meteorological Sciences (2019-I2M-5-046)
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z221100007922041)
- CAMS Innovation Fund for Medical Sciences
- Peking University First Hospital
This publication has 20 references indexed in Scilit:
- Autoantibodies Targeting Nephrin in PodocytopathiesNew England Journal of Medicine, 2024
- Rituximab or Cyclosporine in the Treatment of Membranous NephropathyNew England Journal of Medicine, 2019
- Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective studyClinical and Experimental Nephrology, 2018
- Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic SyndromeJAMA Pediatrics, 2018
- Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndromeClinical Kidney Journal, 2018
- NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic SyndromeJournal of Autoimmunity, 2018
- Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletionClinical and Experimental Nephrology, 2017
- Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trialThe Lancet, 2014
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal VasculitisNew England Journal of Medicine, 2010
- Change of the course of steroid-dependent nephrotic syndrome after rituximab therapyPediatric Nephrology, 2004